The Cigna Group (CI) Revenue — Quarter Ended Sep 30, 2025
Revenue increased in the current quarter compared to both the prior quarter and the same quarter last year. The growth was driven by higher pharmacy revenues and premiums, though premiums declined year-over-year.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue increased in the current quarter compared to both the prior quarter and the same quarter last year. The growth was driven by higher pharmacy revenues and premiums, though premiums declined year-over-year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$69.7B
Revenue reported for this quarter.
Quarter-over-quarter
+3.8%
Change from the immediately preceding quarter.
Year-over-year
+9.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$268.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $65.6B | +28.4% |
| Mar 31, 2025 | $65.5B | +14.4% |
| Jun 30, 2025 | $67.2B | +11.0% |
| Sep 30, 2025 | $69.7B | +9.5% |
Revenue performance
Total revenue rose from the immediately preceding quarter, reflecting continued expansion in pharmacy and fee-based revenues. Net income also improved significantly versus the prior quarter.
Quarterly comparison
Compared to the same quarter one year earlier, total revenue was higher, with pharmacy revenues increasing and premiums declining. The revenue growth rate moderated from the prior quarter's year-over-year pace.
What to watch
Premiums continued to decline year-over-year, a trend that may warrant monitoring in future quarters.